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A 47-year-old woman with gum cancer was diagnosed with acute endogenous endophthalmitis. Serratia
marcescens was cultured from the vitreous and blood samples. A venous access port for chemotherapy
was the only identiﬁable source of infection. After receiving systemic antibiotics therapy, the patient
recovered from the bacteremia but lost her vision as a result of Serratia endophthalmitis.
Copyright  2012, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Endogenous bacterial endophthalmitis is a serious and rare
complication of bacteremia that occurs with an incidence rate of
0.2%.1 It develops when pathogens reach the eye via the blood-
stream, and cross the blood-ocular barrier to cause intraocular
infection. Risk factors for developing endogenous bacterial
endophthalmitis include diabetes mellitus, malignancy, intrave-
nous drug use, and immunodeﬁcient state. Common causative
bacteria differ according to geographic regions. In the non-East
Asian countries, the most common pathogen is Gram-positive
bacteria, such as Staphylococcus aureus and the Streptococcus
species; while in the East Asian countries, Klebsiella pneumoniae,
a Gram-negative bacteria is most common.2 In this case report, we
will present a case of endogenous bacterial endophthalmitis caused
by an unusual intraocular pathogen.
2. Case report
A 47-year-old woman presented to our emergency department
with acute onset of right eye pain, blurred vision, and tearing for 1
day. She had just been discharged from our hospital after receiving
chemotherapy, 1 week prior to her return to the emergencylogy, Kaohsiung Chang Gung
ung District, Kaohsiung City
.
e Ophthalmologic Society of Taiwdepartment due to eye pain. The patient had a low-grade fever but
no other systemic discomforts. The patient’s medical history was
signiﬁcant for having type 2 diabetes mellitus for more than 10
years, and gum cancer which was diagnosed 2 years earlier. The
patient had been receiving concurrent chemoradiotherapy for gum
cancer ever since its diagnosis. Chemotherapy was administrated
through an implantable venous access device (Port-a-Cath) that
was implanted subcutaneously below her left clavicle (Fig. 1).
Upon examination at the emergency department, the patient
was only able to see hand motion at 30 cm away, and had an
intraocular pressure (IOP) of 27 mmHg in her right eye. Slit-lamp
examination showed that the cornea was edematous and was
coated on the endothelial side with keratic precipitates, and that
there were hypopyon and dense ﬁbrinous exudates in the anterior
chamber of the eye. Examination of the fundus was obscured by the
intense inﬂammatory reaction in the anterior chamber and the
vitreous cavity. B-scan ultrasonography of the right eye revealed
dense and heterogenous opacities in the vitreous cavity (Fig. 2).
Orbital computed tomography image showed prominent periocular
fat stranding and diffuse scleral thickening (Fig. 3). The diagnosis of
endogenous endophthalmitis was made based on the above ﬁnd-
ings, and the patient was given a combination of vancomycin,
amikacin, and dexamethasone injected intravitreally into the eye.
Vitreous sample obtained on that day yielded the growth of Serratia
marcescens, while the blood samples drawn from the peripheral
blood were negative for bacterial growth.
The patient was promptly admitted into the hospital for intra-
venous antibiotic therapy, given through a peripheral venousan. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Chest X-ray revealed that the patient had an implanted Port-a-Cath.
Fig. 3. Computed tomography of the orbit showed extensive periocular fat stranding
and diffuse scleral thickening in the right eye.
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but was later switched to ceftriaxone according to drug sensitivity
results from the bacterial cultures. Ultrasonography of the liver,
cardioechography, urinalysis, and chest X-ray for infection survey
were performed, but all yielded negative results.
During hospitalization, the patient’s ocular inﬂammation signs
remained stationary, but she continued to have low-grade fever of
37.7e37.9C. Then, during the third week of hospitalization, the
patient suddenly had a high fever of 39C that was accompanied by
chills and local tenderness near the site of the implanted Port-a-
Cath. Coincidentally, on the same day, the patient had just
switched from the use of a peripheral venous catheter line to the
use of the Port-a-Cath for the administration of antibiotic therapy.
Because of high fever, blood cultures were obtained, and both
samples from the Port-a-Cath and the peripheral catheter yieldedFig. 2. B-scan showed that there were dense vitreous opacities.S. marcescens. Despite the high suspicion for Port-a-Cath-related
infection, the patient needed this venous access port for chemo-
therapy, thus the decisionwasmade not to remove it for tip culture.
Systemic antibiotic was switched to ceftazidime because of
persistent Serratia bacteremia and that this was a catheter-related
bloodstream infection.
The patient received a total of 6 weeks of systemic antibiotic
therapy, and was discharged from the hospital after subsequent
blood cultures no longer yielded bacterial growth. Despite the
improvements in her systemic conditions and ocular inﬂammation,
the patient’s right eye vision eventually progressed to no light
perception, and phthisis bulbi developed.3. Discussion
S. marcescens, an aerobic, Gram-negative bacilli, has become an
increasingly common cause of hospital-acquired infections
worldwide.3e5 It can cause a variety of diseases, including respi-
ratory tract infections, urinary tract infections, bacteremia, wound
infections, keratoconjunctivitis, and meningitis.6 Outbreaks of
S. marcescens bacteremia in the nosocomial setting has been asso-
ciated with high mortality rates of 25.4e32%,4,5 and have been
linked to contaminated preﬁlled syringes and drug vials,7,8 multiple
dose usage for single-use drug vials,9 and inappropriate aseptic
techniques of the healthcare personnels.10
Endogenous endophthalmitis caused by S. marcescens is rare.
Based on our literature search, fewer than 10 well-documented
cases (not including cases written in languages other than in
English) have been reported to date (Table 1).6,11e19 Endogenous
Serratia endophthalmitis has been associated with intravenous
drug therapy, general surgery, and the use of indwelling catheters.6
Additional risk factors include diabetes mellitus, malignancy, and
immunocompromised state.
S. marcescens can be highly destructive to the eye, owing to its
ability to secrete proteases that cause the loss of proteoglycan
ground substances which then lead to the dispersal of collagen
ﬁbrils, liquefactive necrosis, and subsequently, ocular perforation.6
Endogenous Serratia endophthalmitis often leads to very poor
visual outcomes. In their review, Equi and Green6 found that nearly
Table 1
Clinical characteristics of S. marcescens endogenous endophthalmitis in our case and previous reports.
Author (reference) Age, y Sex Comorbidity or risk factors Source of positive
bacterial isolates
Intravitreal
antibiotics
Systemic antibiotics Final outcome
Gammon et al.11 60 Female Craniotomy for intercavernous
aneurysm, indwelling
urinary catheter
Aqueous, urine None Gentamicin/amikin Death
Radda12 59 Male Chronic lymphatic leukemia,
diabetes mellitus, transurethral
electroresection of prostate for
prostate adenoma, hemodialysis,
Vitreous None Amoxicillin/carbenicillin
and gentamicin/ticarcillin/
cefotaxime
Evisceration
de Courten et al.13 10 days male Colostomy for unperforated anus Vitreous, blood None Ceﬂatonin and ampicillin/
ampicillin and amikin
Enucleation
Alverez et al14 32 male HIV infection, intravenous
drug user
Vitreous Tobramycin,
vancomycin
Ceftazidime, amikin, and
vancomycin/ceftriaxone
and amikin
Phthisis bulbi
Al Hazzaa et al.15 3 days Not
speciﬁed
Umbilical artery catheter Blood, catheter
tip, aqueous
Gentamicin,
cefazolin
Gentamicin Phthisis bulbi
Lin et al.16 68 Female Diabetes mellitus, renal abscess Renal abscess
pus culture
Vancomycin,
amikin
Cefazolin/peﬂoxacin/
ceftizoxime
No light
perception
Marinella et al.17 48 Male Diabetes mellitus, hemodialysis,
temporary central venous catheter
Vitreous, aqueous
humor, blood culture
Ceftazidime,
vancomycin
Piperacillin, vancomycin,
and gentamicin/cefotaxime
Enucleation
Equi et al.6 54 Female Diabetes mellitus, hemodialysis,
hypertension, temporary
central venous catheter
Vitreous, blood,
catheter tip
Vancomycin,
gentamicin
Vancomycin and
gentamicin/aztreonam
Enucleation
Williams et al.18 56 Female Bowel resection for Crohn’s
disease, pneumonia
Blood, sputum, Ceftazidime,
vancomycin
Cefuroxime and gentamicin Death
Latorre19 20 days Female Umbilical artery and vein catheters Blood None Amikin/ciproﬂoxacin Enucleation
Our case 47 Female Diabetes mellitus, gum cancer
with port-a-cath
Vitreous, blood Amikin,
vancomycin
Cefepime/ceftriaxone/
ceftazidime
Phthisis bulbi
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endophthalmitis resulted in worse than no light perception,
including death, evisceration, and phthisis bulbi.
Because of this organism’s ability to produce pigment, pig-
mented hypopyon, such as pink15 or dark6 hypopyon can some-
times also be observed in case of endogenous endophthalmitis.
However, even though this is a distinctive feature of Serratia
infection, it cannot be relied upon for diagnosis or identiﬁcation of
the organism, because only a minority of S. marcescens strains
elaborates pigment.6 In our patient, no particular discoloration or
pigmentation of hypopyon upon presentation was noted.
Management of this organism can be difﬁcult because it is
typically a multi-drug resistant organism. A 10-year retrospective
study4 at a tertiary-care hospital showed that the resistance rate to
third-generation cephalosporinwas about 46%, extended-spectrum
penicillin was 57%, and ciproﬂoxacin was 32%.
Bacteria can be introduced into the blood resulting in bacter-
emia through various portals of entry, and may cause endogenous
endophthalmitis when the bacteria are inoculated in the eye via
hematogenous spread. Our patient had no history of penetrating
injury or surgery to the eye, which suggests that her endoph-
thalmitis was endogenous, and that the bacteria came from the
bloodstream. Even though S. marcescens was cultured from our
patient’s vitreous initially, her ﬁrst set of blood culture, which was
obtained from the peripheral vein instead of from her Port-a-Cath,
had no bacterial growth. In a review comparing blood cultures
obtained from intravascular catheters and peripheral vein, Falagas
et al.20 showed that the blood drawn from peripheral vein had
a higher false negative rate, and could result in undertreatment of
true bacteremia. Furthermore, we speculate that based her initial
subclinical systemic presentation, the bacterial load in her blood
could have been relatively low, whichmay have resulted in a falsely
negative bacterial yield. As a survey for infection source revealed no
apparent source of infection other than her catheter, and also
because subsequent blood culture obtained from the Port-a-Cath
grew the same bacteria as the vitreous, makes the Port-a-Cath
the mostly likely portal of entry for the bacteria. In addition tohaving an intravascular device, she also had type 2 diabetes mel-
litus and gum cancer, which together made her vulnerable to
developing endogenous endophthalmitis.
The Port-a-Cath is an implantable venous access device that is
composed of a catheter that connects a portal to the large vein. It is
commonly used for receiving chemotherapy or parenteral nutrition
in cancer patients, but is also the leading cause of health-care related
bloodstream infections21 in this group of patients. The deﬁnitive
diagnosis of catheter-related blood stream infections is typically
made by the removal of the catheter and obtaining a catheter tip
culture. However, catheters cannot always be removed easily, espe-
cially when the catheters are long-term catheters, need to be surgi-
cally removed, or when insertion of a new catheter is difﬁcult. The
Port-a-Cath of our patient was not removed because she depended
on it for chemotherapy, and because the patientwas physicallyweak
and could not withstand another surgical procedure.
In a recently updated guideline by the Infectious Diseases
Society of America22 in 2009, two methods for deﬁnitive diagnosis
of catheter-related bloodstream infection (CRBSI) without the
removal of catheters were also listed, which are the quantitative
blood culture method and the differential time to positivity
method. Two blood samples need to be obtained, one drawn from
the catheter, and the other from the peripheral vein. For the
quantitative blood culture method, a deﬁnitive diagnosis of CRBSI is
made when the colony count of microbes grown from the blood
obtained from the catheter is threefold greater than the colony
count of the blood obtained from a peripheral vein. For the differ-
ential time to positivity method for diagnosing CRBSI, growth of
microbes from the blood drawn from a catheter occurs >2 hours
before microbial growth is detected in a blood sample obtained
from a peripheral vein. The above catheter-sparing methods are
high in sensitivity and speciﬁcity (sensitivity 93% and 89e90%,
respectively; speciﬁcity 97e100% and 72e87%, respectively),21
and facilitate accurate diagnosis of CRBSI without the removal of
catheters. The differential time to positivity method is a simple
technique and can be done in most laboratories; however, the
routine recording of time to positivity for microbial growth was not
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piece of information was not available to us, and a deﬁnite diag-
nosis of Port-a-Cath infection could not be made in our case.
Nevertheless, a high degree of suspicion remains for the Port-a-
Cath as the source of infection, as no other apparent source or
portal of entry for infection could be found in our patient.
In the case of our patient, it is possible that the bacteria had
already been colonized within the port, and may have beenwashed
into the bloodstream with each use of the Port-a-Cath, which
consequently resulted in the infection of the eye and the blood-
stream. Therefore, it is important to recognize Port-a-Cath as
a potential portal of entry for bacteria in cancer patients who
present with endogenous endophthalmitis, particularly when no
other infection source could be identiﬁed.
In conclusion, because endogenous endophthalmitis is a severe
complication of bloodstream infection with devastating conse-
quences, a detailed evaluation, including physical examination and
recording of medical history is essential, so that any indwelling
catheters or intravascular devices, particularly the Port-a-Cath in
cancer patients are not missed. Furthermore, when unusual path-
ogens are encountered in cancer patients with endogenous
endophthalmitis, catheter- related infections should be ruled out
because intravascular devices may allow unusual and aggressive
pathogens to gain access to the eye via the bloodstream.References
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